Financhill
Back

Protagonist Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

Protagonist Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 54.98 Buy
20-day SMA: 50.12 Buy
50-day SMA: 46.71 Buy
200-day SMA: 43.94 Buy
8-day EMA: 54.62 Buy
20-day EMA: 51.36 Buy
50-day EMA: 48.17 Buy
200-day EMA: 42.86 Buy

Protagonist Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.94 Buy
Relative Strength Index (14 RSI): 75.11 Buy
Chaikin Money Flow: 12043 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.35 - 53.49) Buy
Bollinger Bands (100): (38.6 - 50.9) Buy

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Protagonist Therapeutics Stock

Is Protagonist Therapeutics Stock a Buy?

PTGX Technical Analysis vs Fundamental Analysis

Buy
53
Protagonist Therapeutics (PTGX) is a Buy

Is Protagonist Therapeutics a Buy or a Sell?

Protagonist Therapeutics Stock Info

Market Cap:
3.5B
Price in USD:
56.37
Share Volume:
987.5K

Protagonist Therapeutics 52-Week Range

52-Week High:
60.60
52-Week Low:
30.67
Buy
53
Protagonist Therapeutics (PTGX) is a Buy

Protagonist Therapeutics Share Price Forecast

Is Protagonist Therapeutics Stock a Buy?

Fundamental Analysis of Protagonist Therapeutics

Is Protagonist Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.13 per share, a decrease this year of $4.12 per share, and an increase next year of $0.45 per share.

Technical Analysis of Protagonist Therapeutics

Should I short Protagonist Therapeutics stock?

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.